Gan & Lee Pharmaceuticals.

603087.SS·Shanghai·Healthcare
Compare
72.32+0.34 (+0.47%)today
At close: Nov 5, 3:00 PM CST · May be delayed up to 15 min · CNY

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close71.98
Open71.90
Day range71.6673.73
52-week range51.5179.99
Off day high−1.91%
Off 52-week high−9.59%
Volume7.35M
Avg. volume (3M)10.12M
Market cap43.21B
EPS (TTM)2.00
Forward P/E38.06
P/E ratio (TTM)36.16
Dividend yield1.39% (1.00)
Beta (5Y)0.34
Shares outstanding597.43M
Short interest—
Earnings dateApr 29, 2022
Analyst target83.50
Profit margin27.05%

Against its peers

Compare in full ›
603087.SS 1066.HK MMED 600867.SS 000661.SZ 3759.HK
Market cap 43.21B 15.14B 5.43B 15.73B 30.39B 55.85B
P/E (TTM) 36.2 10.2 — 28.7 — 27.4
Forward P/E 38.1 8.1 27.8 22.3 6.7 17.2
Price/book 3.6 0.5 1.5 2.1 1.3 2.8
Dividend yield 1.39% 5.23% — 3.75% 0.22% 0.78%
1-year change +12.15% −41.03% +4.33% −11.78% −30.53% +19.72%
Today +0.47% +4.81% +2.33% +0.25% +1.78% +3.47%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

BioSpace·Positive

A New Paradigm for Long-Term Weight Management: Once-Monthly Bofanglutide Maintenance Therapy Delivers Positive Results in Weight Control and Maintenance Over 24 Weeks -- Gan & Lee Pharmaceuticals' GRADUAL-3 Study Meets Its Primary Endpoint

BEIJING and BRIDGEWATER, Mass., Nov. 4, 2026 /CNW/ -- Gan & Lee Pharmaceuticals (Stock Code: 603087. SH) announced positive topline results from GRADUAL-3, a Phase III clinical study evaluating once-monthly administration of its…

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance